|
Cervix:
Endometrial:
Ovarian/Peritoneal:
-
GOG 213: A Phase III Randomized controlled Clinical
Trial of Carboplatin and Paclitaxel Alone or in Combination
with Bevacizumab (NSC#704865, IND#7921) Followed by
Bevacizumab and Secondary Cytoreductive Surgery in
Platinum-Sensitive, Recurrent Ovarian, Perinoneal Primary
and Fallopian Tube Cancer
-
GOG 0187: Phase II Study of Paclitaxel for Ovarian
Stromal Tumors as Second-Line Treatment
Vulva:
For more information on the above clinical
trials:
Cheryl Patz, RN, OCN, CCRC, 360.715.4133
Return to previous page
|